About AVRA Laboratories
AVRA Laboratories is a company based in Hyderabad (India) founded in 1995 was acquired by Advent International in January 2022. The company has 371 employees as of March 28, 2024. AVRA Laboratories offers products and services including Slot Gaming Platform. AVRA Laboratories operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 371 as on 28 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Avra Laboratories Private Limited
- Date of Incorporation 20 Jul, 1995
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$39.6 M (USD)150.75as on Mar 31, 2017
-
Net Profit
$10.35 M (USD)544.82as on Mar 31, 2017
-
EBITDA
$18.57 M (USD)310.5as on Mar 31, 2017
-
Latest Funding Round
Not available
- Investors
-
Employee Count
371
as on Mar 28, 2024
-
Acquired by
Advent International
(Jan 24, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AVRA Laboratories
AVRA Laboratories offers a comprehensive portfolio of products and services, including Slot Gaming Platform.
Platform for secure and fair online slot game playing.
People of AVRA Laboratories
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of AVRA Laboratories
Detailed funding history for AVRA Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AVRA Laboratories
AVRA Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advent International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for AVRA Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AVRA Laboratories
Investment portfolio details for AVRA Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AVRA Laboratories
Detailed financials for AVRA Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avra Laboratories Comparisons
Peer comparison for AVRA Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AVRA Laboratories
AVRA Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of AVRA Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avra Laboratories
Complete news archive for AVRA Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AVRA Laboratories
AVRA Laboratories was founded in 1995.
AVRA Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 28, 2024, the latest employee count at AVRA Laboratories is 371.
Annual revenue of AVRA Laboratories is $39.6M as on Mar 31, 2017.
Avra Laboratories was founded in 1995 in Hyderabad, India, as a CRAMS provider in the pharmaceutical sector. Custom synthesis services are delivered, including route identification and optimization for compounds scaled from multi-gram to multi-ton levels. Operations are supported by four manufacturing facilities, one approved by the US FDA. APIs, intermediates, and specialty generics are produced, with capabilities for highly potent APIs at OEL levels from 10 μgm to 1 μgm.
AVRA Laboratories's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
AVRA Laboratories offers Slot Gaming Platform.
AVRA Laboratories has 1 investor. Key investors include Advent International.